未登录返回期刊详情
A hyperimmune ovine antibody-based therapeutic candidate against Crimean-Congo haemorrhagic fever virus targeted to the Gn and Gc glycoproteins: high antibody levels with neutralization activity but lack of protective efficacy in a mouse model一种靶向Crimean-Congo haemorrhagic fever virus的Gn和Gc糖蛋白的高免疫绵羊抗体基治疗候选药物：具有中和活性的高抗体水平，但在小鼠模型中缺乏保护效力
Kennedy, Emma; Findlay-Wilson, Stephen; Webster, Sarah; Rajabzadeh, Annahita; Fotheringham, Susan; Easterbrook, Linda; Chambers, Adam; Aksular, Mine; Possee, Robert; Smith, Sandra; Pope, Neville; Griffiths, Aled; Arnold, Ulrike; Jackson, David; Ruedas-Torres, Ines; Salguero, Francisco Javier; Dowall, Stuart.png)
分享.png)
收藏 Development of SDP0505: a first-in-class HER3 × c-Met bispecific ADC, demonstrates potent antitumor activity in EGFR TKI-resistant NSCLC, CRC, and beyondSDP0505的开发：一种首创的HER3 × c-Met双特异性抗体药物偶联物，在EGFR TKI耐药的NSCLC、CRC及更广泛适应症中显示出强大的抗肿瘤活性Wang, Li-Min; Yang, Changyong; Chen, Simeng; Sun, Xing; Tian, Yunan; Zhang, Jieqiong; Gao, Xiaomeng; Li, Dan; Zhang, Wei; Hu, Yali; Yuan, Jimin; Xu, Qumiao; Liu, Xiyang; Zhang, Long; Yu, Qianqian; Liao, Cheng 分享 收藏 Affinity-optimized TROP2 antibodies support potent antitumor activity in antibody-drug conjugates亲和力优化的TROP2抗体在抗体-药物偶联物中支持强效抗肿瘤活性Yamaguchi, Aiko; Hong, Junping; Li, Leike; Kobayashi, Kiyotaka; Yamazaki, Chisato M.; Ha, Summer Y. Y.; Anami, Yasuaki; Xiong, Wei; Liu, Junquan; An, Zhiqiang; Zhang, Ningyan; Tsuchikama, Kyoji 分享 收藏 Analysis of the use of monoclonal antibodies in the treatment of Crohn's disease单克隆抗体在克罗恩病治疗中的应用分析Blagov, Alexander, V; Sazonova, Marina D.; Ryzhkova, Anastasia, I; Karagodin, Vasily P.; Popov, Mikhail A.; Budnikov, Egor Yu; Ravani, Alessio L.; Orekhov, Alexander N.; Sazonova, Margarita A.; Arkhipenko, Yuri, V 分享 收藏 IMM2510, a novel anti-PD-L1/VEGF bispecific antibody for cancer immunotherapyIMM2510，一种新型抗PD-L1/VEGF双特异性抗体用于癌症免疫治疗Chen, Dianze; Wu, Zhuli; Zhao, Xiwen; Bhatt, Rupal S.; Yang, Yanan; Zhu, Wenqi; Tang, Huang; Wang, Kaili; Guo, Chunli; Liu, Dandan; Yang, Chunmei; Guo, Huiqin; Bai, Xing; Zhang, Ruliang; Li, Song; Tian, Wenzhi 分享 收藏 Bispecific and multispecific T-cell engagers: advancing the future of immunotherapyKang, X.; Zhao, Y.; Ling, H.; Huang, X. 双特异性及多特异性T细胞结合剂：推动免疫治疗未来。Antib. Ther. 2025, 9, 58–69. [Google Scholar] [CrossRef] [PubMed]Kang, Xiaoqiang; Zhao, Yue; Ling, Hong; Huang, Xiao 分享 收藏 Unique loop-structured CD19/CD22 bispecific CAR-T-cell therapy for patients with relapsed/refractory diffuse large B-cell lymphoma: an observational study独特的环状结构CD19/CD22双特异性CAR-T细胞疗法治疗复发/难治性弥漫大B细胞淋巴瘤：一项观察性研究Li, Shuhong; Liu, Liqiong; Liu, Zelin; Li, Jianjiang; Zhou, Huanhuan; Zhong, Nan; Ye, Yuan; Zhao, Lijun; Liang, Xiao; Shi, Yuanyuan; Cao, Yu J.; Guo, Zhi 分享 收藏 The development of a next generation NK cell engager platform by integrating a potency-reduced IL-15 variant to enhance antitumor activity通过整合效力降低的IL-15变体来增强抗肿瘤活性，开发下一代NK细胞结合剂平台Wang, Lijun; Ding, Yinhui; Lv, Huifeng; Yang, Yang; Chen, Mengting; Shi, Beilei; Ma, Zelong; Hu, Li; Zhang, Rui; Wu, Danqing; Gong, Shiyong; Wu, Chengbin; Wu, Xuan 分享 收藏 Overcoming antigen tolerance to develop GB22-45-2, an anti-DKK1 antibody for gastric cancer克服抗原耐受以开发GB22-45-2，一种用于胃癌的anti-DKK1抗体Zhang, Wenjun; Wei, Xiling; Yao, Tianqi; Liang, Binghui; Yang, Xiaodong; Peng, Yiyuan; Yin, Tianqi; Dong, Wei; Li, Huiming; Guo, Xiuli; Qin, Suofu 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png)
